The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
Authors
Keywords
-
Journal
JAMA Network Open
Volume 5, Issue 3, Pages e222973
Publisher
American Medical Association (AMA)
Online
2022-03-18
DOI
10.1001/jamanetworkopen.2022.2973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
- (2021) Patricia R. M. Rocco et al. EUROPEAN RESPIRATORY JOURNAL
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of a Serious Game, “Escape COVID-19”, on the Intention to Change COVID-19 Control Practices among Employees of Long-term Care Facilities: Web-Based, Randomized Controlled Trial (Preprint)
- (2021) Mélanie Suppan et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial
- (2021) Alejandro jose Gonzalez Ochoa et al. THROMBOSIS AND HAEMOSTASIS
- The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial
- (2021) Zhijian Luo et al. European Journal of Integrative Medicine
- Effect of Clear vs Standard Covered Masks on Communication With Patients During Surgical Clinic Encounters
- (2021) Ian M. Kratzke et al. JAMA Surgery
- Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
- (2021) Dongsheng Wang et al. Frontiers of Medicine
- Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial
- (2021) Janine Alessi et al. ACTA DIABETOLOGICA
- Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
- (2021) Amirreza Roostaei Firozabad et al. BMC INFECTIOUS DISEASES
- Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
- (2021) Keivan Ranjbar et al. BMC INFECTIOUS DISEASES
- Effect of ivermectin on COVID-19: A multicenter double-blind randomized controlled clinical trial
- (2021) Leila Shahbaznejad et al. CLINICAL THERAPEUTICS
- Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure
- (2021) Domenico Luca Grieco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
- (2021) Reaz Mahmud et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
- (2021) Álvaro Réa-Neto et al. Scientific Reports
- Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
- (2021) Alexander Supady et al. Lancet Respiratory Medicine
- Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19
- (2021) Zaki F Aref et al. International Journal of Nanomedicine
- Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities
- (2021) Myron S. Cohen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India
- (2021) Ravikirti et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
- (2021) Renato D Lopes et al. LANCET
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial
- (2021) Shuang Zhou et al. PHYTOMEDICINE
- Umbilical cord mesenchymal stromal cells as critical COVID ‐19 adjuvant therapy: A randomized controlled trial
- (2021) Ismail Hadisoebroto Dilogo et al. Stem Cells Translational Medicine
- Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial
- (2021) Sara Policarpo et al. Clinical Nutrition ESPEN
- Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality
- (2021) Kimia Honarmand et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
- (2020) Ke Hu et al. PHYTOMEDICINE
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
- (2020) Caleb P. Skipper et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
- (2020) Effat Davoudi-Monfared et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial
- (2020) Jia-bo Wang et al. Chinese Journal of Integrative Medicine
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The COVID-19 infodemic
- (2020) The Lancet Infectious Diseases LANCET INFECTIOUS DISEASES
- Fragility Analysis of Statistically Significant Outcomes of Randomised Control Trials in Spine Surgery
- (2020) Muthu Sathish et al. SPINE
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic
- (2020) Isabelle Boutron et al. ANNALS OF INTERNAL MEDICINE
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
- (2020) Maryam Edalatifard et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
- (2020) Lin-ling Cheng et al. JAMA Internal Medicine
- The Fragility Index and Trial Significance
- (2020) Alexander Chaitoff et al. JAMA Internal Medicine
- Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Ruanne V. Barnabas et al. ANNALS OF INTERNAL MEDICINE
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
- (2020) Eric J. Lenze et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
- (2020) Fatemeh Roozbeh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Scientists rise up against statistical significance
- (2019) Valentin Amrhein et al. NATURE
- The fragility of statistically significant findings in randomised controlled anaesthesiology trials: systematic review of the medical literature
- (2018) G. Mazzinari et al. BRITISH JOURNAL OF ANAESTHESIA
- The Fragility and Reliability of Conclusions of Anesthesia and Critical Care Randomized Trials With Statistically Significant Findings
- (2018) François Grolleau et al. CRITICAL CARE MEDICINE
- The fragility of significant results underscores the need of larger randomized controlled trials in nephrology
- (2017) Lani R. Shochet et al. KIDNEY INTERNATIONAL
- The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey
- (2016) Moin Khan et al. AMERICAN JOURNAL OF SPORTS MEDICINE
- The ASA's Statement onp-Values: Context, Process, and Purpose
- (2016) Ronald L. Wasserstein et al. AMERICAN STATISTICIAN
- The Fragility Index in Multicenter Randomized Controlled Critical Care Trials*
- (2016) Elliott E. Ridgeon et al. CRITICAL CARE MEDICINE
- The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey
- (2015) Nathan Evaniew et al. Spine Journal
- The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index
- (2014) Michael Walsh et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started